Total Payments
$20,029
2024 Payments
$2,149
Companies
68
Transactions
1,231
Medicare Patients
4,456
Medicare Billing
$352,926
Payment Breakdown by Category
Food & Beverage$18,866 (94.2%)
Other$510.00 (2.5%)
Education$392.61 (2.0%)
Gifts$140.00 (0.7%)
Consulting$120.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,866 | 1,214 | 94.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $510.00 | 4 | 2.5% |
| Education | $392.61 | 11 | 2.0% |
| Gift | $140.00 | 1 | 0.7% |
| Consulting Fee | $120.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,728 | 184 | $0 (2024) |
| Lilly USA, LLC | $1,402 | 104 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,265 | 113 | $0 (2024) |
| ABBVIE INC. | $1,230 | 92 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,133 | 56 | $0 (2024) |
| Amarin Pharma Inc. | $1,113 | 80 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $845.51 | 40 | $0 (2024) |
| Allergan, Inc. | $756.93 | 79 | $0 (2022) |
| Merck Sharp & Dohme LLC | $631.47 | 38 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $619.79 | 22 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,149 | 119 | Amgen Inc. ($640.25) |
| 2023 | $2,424 | 134 | Amgen Inc. ($510.80) |
| 2022 | $2,856 | 153 | Amgen Inc. ($810.30) |
| 2021 | $3,208 | 197 | Amgen Inc. ($612.39) |
| 2020 | $3,022 | 193 | Amgen Inc. ($499.02) |
| 2019 | $2,186 | 148 | Amarin Pharma Inc. ($383.46) |
| 2018 | $2,403 | 156 | Amgen Inc. ($297.60) |
| 2017 | $1,781 | 131 | Novo Nordisk Inc ($303.68) |
All Payment Transactions
1,231 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: GI | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Neurology | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Biological | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $28.74 | General |
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,143 | 1,874 | $195,610 | $101,739 |
| 2022 | 20 | 1,148 | 1,981 | $188,553 | $94,346 |
| 2021 | 18 | 1,085 | 1,774 | $128,172 | $80,256 |
| 2020 | 19 | 1,080 | 1,821 | $118,707 | $76,585 |
Total Patients
4,456
Total Services
7,450
Medicare Billing
$352,926
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 643 | $96,450 | $41,941 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 104 | 104 | $18,720 | $13,806 | 73.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 144 | $28,800 | $13,161 | 45.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 130 | 132 | $10,560 | $9,478 | 89.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $3,900 | $3,702 | 94.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 70 | $7,000 | $2,952 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 129 | 131 | $2,620 | $2,568 | 98.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $3,000 | $2,537 | 84.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,640 | $2,034 | 77.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 21 | $2,940 | $1,695 | 57.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 20 | $2,300 | $1,406 | 61.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 147 | 153 | $1,530 | $1,277 | 83.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 24 | $2,040 | $1,206 | 59.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 112 | $5,600 | $1,170 | 20.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 24 | $1,560 | $897.92 | 57.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 14 | 14 | $1,260 | $650.00 | 51.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 36 | $1,620 | $416.15 | 25.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 22 | $1,100 | $357.32 | 32.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $360.00 | $352.80 | 98.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 161 | $1,610 | $131.27 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 196 | 615 | $92,250 | $39,513 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 162 | $32,400 | $14,787 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 94 | 94 | $15,153 | $12,144 | 80.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 135 | 138 | $9,690 | $8,672 | 89.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 18 | 18 | $3,465 | $3,085 | 89.0% |
About Dr. John Heidrick, D.O
Dr. John Heidrick, D.O is a Family Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447252754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Heidrick, D.O has received a total of $20,029 in payments from pharmaceutical and medical device companies, with $2,149 received in 2024. These payments were reported across 1,231 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($18,866).
As a Medicare-enrolled provider, Heidrick has provided services to 4,456 Medicare beneficiaries, totaling 7,450 services with total Medicare billing of $352,926. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bakersfield, CA
- Active Since 06/01/2005
- Last Updated 09/18/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447252754
Products in Payments
- XIFAXAN (Drug) $1,241
- Vascepa (Drug) $1,113
- Aimovig (Biological) $1,088
- JARDIANCE (Drug) $951.51
- Otezla (Drug) $931.21
- Repatha (Biological) $703.09
- VRAYLAR (Drug) $695.98
- UBRELVY (Drug) $563.65
- EMGALITY (Drug) $525.77
- FARXIGA (Drug) $501.48
- EVENITY (Biological) $476.76
- TROKENDI XR (Drug) $475.83
- Trintellix (Drug) $392.81
- TEZSPIRE (Biological) $381.61
- MOUNJARO (Drug) $377.05
- NURTEC ODT (Drug) $351.46
- SOLIQUA 100/33 (Biological) $329.29
- JANUVIA (Drug) $310.03
- REXULTI (Drug) $307.64
- NEXLETOL (Drug) $300.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bakersfield
Mrs. Amira Ayad, M.d, M.D
Family Medicine — Payments: $278,616
Family Medicine $278,616
Matthew Beare, M.d, M.D
Family Medicine — Payments: $81,707
Family Medicine $81,707
Tien Nguyen, M.d, M.D
Family Medicine — Payments: $25,013
Family Medicine $25,013
Neha Chande, M.d., M.h.s, M.D., M.H.S
Family Medicine — Payments: $20,779
Family Medicine $20,779
Dr. Kamrun Naher, M.d, M.D
Family Medicine — Payments: $18,386
Family Medicine $18,386
Dr. Ashokkumar Ghadia, M.d, M.D
Family Medicine — Payments: $16,231
Family Medicine $16,231